Covered recipient · General Payments record
BARBARA E SALAMON
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$1,594.14
- Reported across 104 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $451.37 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $263.57 | 17 |
| Daiichi Sankyo Inc. | $39.33 | 2 |
| PFIZER INC. | $33.52 | 2 |
| Lilly USA, LLC | $32.50 | 2 |
| Ardelyx, Inc. | $26.18 | 1 |
| Phathom Pharmaceuticals, Inc. | $19.42 | 1 |
| Amgen Inc. | $19.07 | 1 |
| Novo Nordisk AS | $17.78 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $2.90 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106003569 | CMS |
| ABBVIE INC. | $15.76 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106003571 | CMS |
| ABBVIE INC. | $14.18 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106003573 | CMS |
| ABBVIE INC. | $22.72 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106003575 | CMS |
| ABBVIE INC. | $7.06 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106003577 | CMS |
| ABBVIE INC. | $13.01 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106003579 | CMS |
| ABBVIE INC. | $12.08 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106003581 | CMS |
| ABBVIE INC. | $10.51 | 08/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106003583 | CMS |
| ABBVIE INC. | $12.83 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106003585 | CMS |
| ABBVIE INC. | $16.67 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106003587 | CMS |
| ABBVIE INC. | $12.43 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106003589 | CMS |
| ABBVIE INC. | $12.86 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106003591 | CMS |
| ABBVIE INC. | $25.02 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106003593 | CMS |
| ABBVIE INC. | $23.98 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106003595 | CMS |
| ABBVIE INC. | $20.71 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106003597 | CMS |
| ABBVIE INC. | $12.86 | 11/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106003599 | CMS |
| ABBVIE INC. | $27.99 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106003601 | CMS |
| Amgen Inc. | $19.07 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117372440 | CMS |
| Ardelyx, Inc. | $26.18 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146705427 | CMS |
| Daiichi Sankyo Inc. | $18.59 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089477449 | CMS |
| Daiichi Sankyo Inc. | $20.74 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089477447 | CMS |
| Lilly USA, LLC | $16.36 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136073209 | CMS |
| Lilly USA, LLC | $16.14 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136061910 | CMS |
| Novo Nordisk Inc | $17.78 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096923378 | CMS |
| PFIZER INC. | $16.76 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131453989 | CMS |
| PFIZER INC. | $16.76 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131776171 | CMS |
| Phathom Pharmaceuticals, Inc. | $19.42 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151119498 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.